REGN Filing
4Filing Date: Apr 3, 2026

REGENERON PHARMACEUTICALS, INC. (REGN) · Insider Trading (Form 4) SEC Filing

Statement of Changes in Beneficial Ownership

descriptionView SEC Filing
ACC: 0001104659-26-039613open_in_new
Total Value$71.5K
Trades8
Insiders1

Transaction Details

RYAN ARTHUR F
Director·Direct
Sell · Dispose
Common Stock
Shares-8
Price$773.59
Total Value$6.2K
Shares Owned After17.69K
Transaction DateApr 1, 2026
10b5-1
Footnotes ▸

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. | Represents volume-weighted average price of sales of 8 shares of Company stock on April 1, 2026 at prices ranging from $773.27 to $773.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price.

RYAN ARTHUR F
Director·Direct
Sell · Dispose
Common Stock
Shares-40
Price$779.71
Total Value$31.2K
Shares Owned After17.60K
Transaction DateApr 1, 2026
10b5-1
Footnotes ▸

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. | Represents volume-weighted average price of sales of 40 shares of Company stock on April 1, 2026 at prices ranging from $779.65 to $779.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price.

RYAN ARTHUR F
Director·Direct
Sell · Dispose
Common Stock
Shares-1
Price$771.32
Total Value$771.32
Shares Owned After17.70K
Transaction DateApr 1, 2026
10b5-1
Footnotes ▸

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025.

RYAN ARTHUR F
Director·Direct
Sell · Dispose
Common Stock
Shares-3
Price$772.76
Total Value$2.3K
Shares Owned After17.70K
Transaction DateApr 1, 2026
10b5-1
Footnotes ▸

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. | Represents volume-weighted average price of sales of 3 shares of Company stock on April 1, 2026 at prices ranging from $772.62 to $772.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price.

RYAN ARTHUR F
Director·Direct
Sell · Dispose
Common Stock
Shares-14
Price$775.58
Total Value$10.9K
Shares Owned After17.67K
Transaction DateApr 1, 2026
10b5-1
Footnotes ▸

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. | Represents volume-weighted average price of sales of 14 shares of Company stock on April 1, 2026 at prices ranging from $775.04 to $775.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price.

RYAN ARTHUR F
Director·Direct
Sell · Dispose
Common Stock
Shares-4
Price$778.24
Total Value$3.1K
Shares Owned After17.64K
Transaction DateApr 1, 2026
10b5-1
Footnotes ▸

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. | Represents volume-weighted average price of sales of 4 shares of Company stock on April 1, 2026 at prices ranging from $778.02 to $778.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price.

RYAN ARTHUR F
Director·Direct
Sell · Dispose
Common Stock
Shares-9
Price$777.42
Total Value$7.0K
Shares Owned After17.65K
Transaction DateApr 1, 2026
10b5-1
Footnotes ▸

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. | Represents volume-weighted average price of sales of 9 shares of Company stock on April 1, 2026 at prices ranging from $777.03 to $777.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price.

RYAN ARTHUR F
Director·Direct
Sell · Dispose
Common Stock
Shares-13
Price$776.62
Total Value$10.1K
Shares Owned After17.66K
Transaction DateApr 1, 2026
10b5-1
Footnotes ▸

Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. | Represents volume-weighted average price of sales of 13 shares of Company stock on April 1, 2026 at prices ranging from $776.11 to $776.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price.

Post-Transaction Holdings

RYAN ARTHUR F
SecuritySharesChange
Common Stock17.69K-92 (-0.52%)
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership === Document Type: 4 Period of Report: 2026-04-01 10b5-1 Pre-arranged Plan: Yes --- Issuer --- Name: REGENERON PHARMACEUTICALS, INC. (REGN) CIK: 0000872589 --- Reporting Owner --- Name: RYAN ARTHUR F CIK: 0001187443 Role: Director --- Non-Derivative Transactions --- [Transaction #1] Security: Common Stock Date: 2026-04-01 | Code: S (Open market sale) Shares: -1 | Price: $771.32 Total Value: $771.32 Shares Owned After: 17,702 | Ownership: D (Direct) Footnotes: [F1] Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. [Transaction #2] Security: Common Stock Date: 2026-04-01 | Code: S (Open market sale) Shares: -3 | Price: $772.76 Total Value: $2,318.28 Shares Owned After: 17,699 | Ownership: D (Direct) Footnotes: [F1] Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. [F2] Represents volume-weighted average price of sales of 3 shares of Company stock on April 1, 2026 at prices ranging from $772.62 to $772.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. [Transaction #3] Security: Common Stock Date: 2026-04-01 | Code: S (Open market sale) Shares: -8 | Price: $773.59 Total Value: $6,188.72 Shares Owned After: 17,691 | Ownership: D (Direct) Footnotes: [F1] Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. [F3] Represents volume-weighted average price of sales of 8 shares of Company stock on April 1, 2026 at prices ranging from $773.27 to $773.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. [Transaction #4] Security: Common Stock Date: 2026-04-01 | Code: S (Open market sale) Shares: -8 | Price: $774.58 Total Value: $6,196.64 Shares Owned After: 17,683 | Ownership: D (Direct) Footnotes: [F1] Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. [F4] Represents volume-weighted average price of sales of 8 shares of Company stock on April 1, 2026 at prices ranging from $774.05 to $774.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. [Transaction #5] Security: Common Stock Date: 2026-04-01 | Code: S (Open market sale) Shares: -14 | Price: $775.58 Total Value: $10,858.12 Shares Owned After: 17,669 | Ownership: D (Direct) Footnotes: [F1] Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. [F5] Represents volume-weighted average price of sales of 14 shares of Company stock on April 1, 2026 at prices ranging from $775.04 to $775.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. [Transaction #6] Security: Common Stock Date: 2026-04-01 | Code: S (Open market sale) Shares: -13 | Price: $776.62 Total Value: $10,096.06 Shares Owned After: 17,656 | Ownership: D (Direct) Footnotes: [F1] Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. [F6] Represents volume-weighted average price of sales of 13 shares of Company stock on April 1, 2026 at prices ranging from $776.11 to $776.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. [Transaction #7] Security: Common Stock Date: 2026-04-01 | Code: S (Open market sale) Shares: -9 | Price: $777.42 Total Value: $6,996.78 Shares Owned After: 17,647 | Ownership: D (Direct) Footnotes: [F1] Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. [F7] Represents volume-weighted average price of sales of 9 shares of Company stock on April 1, 2026 at prices ranging from $777.03 to $777.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. [Transaction #8] Security: Common Stock Date: 2026-04-01 | Code: S (Open market sale) Shares: -4 | Price: $778.24 Total Value: $3,112.96 Shares Owned After: 17,643 | Ownership: D (Direct) Footnotes: [F1] Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. [F8] Represents volume-weighted average price of sales of 4 shares of Company stock on April 1, 2026 at prices ranging from $778.02 to $778.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. [Transaction #9] Security: Common Stock Date: 2026-04-01 | Code: S (Open market sale) Shares: -40 | Price: $779.71 Total Value: $31,188.40 Shares Owned After: 17,603 | Ownership: D (Direct) Footnotes: [F1] Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. [F9] Represents volume-weighted average price of sales of 40 shares of Company stock on April 1, 2026 at prices ranging from $779.65 to $779.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. --- Footnotes (Complete Index) --- F1: Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on October 31, 2025. F2: Represents volume-weighted average price of sales of 3 shares of Company stock on April 1, 2026 at prices ranging from $772.62 to $772.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. F3: Represents volume-weighted average price of sales of 8 shares of Company stock on April 1, 2026 at prices ranging from $773.27 to $773.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. F4: Represents volume-weighted average price of sales of 8 shares of Company stock on April 1, 2026 at prices ranging from $774.05 to $774.94. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. F5: Represents volume-weighted average price of sales of 14 shares of Company stock on April 1, 2026 at prices ranging from $775.04 to $775.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. F6: Represents volume-weighted average price of sales of 13 shares of Company stock on April 1, 2026 at prices ranging from $776.11 to $776.84. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. F7: Represents volume-weighted average price of sales of 9 shares of Company stock on April 1, 2026 at prices ranging from $777.03 to $777.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. F8: Represents volume-weighted average price of sales of 4 shares of Company stock on April 1, 2026 at prices ranging from $778.02 to $778.59. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. F9: Represents volume-weighted average price of sales of 40 shares of Company stock on April 1, 2026 at prices ranging from $779.65 to $779.76. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on April 1, 2026 at each separate price. --- Signature --- /s/ /s/ Arthur Ryan (2026-04-03)

keid AI analysis is for reference only and does not constitute investment advice.